Company Filing History:
Years Active: 2013-2017
Title: Antal Friesz: Innovator in Pharmaceutical Chemistry
Introduction
Antal Friesz is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for the preparation of dronedarone, a medication used to treat heart conditions. With a total of 13 patents to his name, Friesz continues to push the boundaries of innovation in his field.
Latest Patents
Friesz's latest patents include a novel process for the preparation of dronedarone using dibutylaminopropanol reagent. This invention involves reacting a compound with a leaving group with another compound to isolate the product, which can then be converted into a pharmaceutically acceptable salt. Another significant patent focuses on the removal of a hydroxyl group from dronedarone, allowing for the isolation of the product and its conversion into a pharmaceutically acceptable salt.
Career Highlights
Antal Friesz is currently employed at Sanofi, a global healthcare leader. His work at Sanofi has allowed him to develop innovative solutions that enhance the efficacy and safety of pharmaceutical products. His expertise in chemical processes has positioned him as a key player in the pharmaceutical industry.
Collaborations
Friesz has collaborated with several talented individuals in his field, including Zsolt Dombrády and Mariann Csatarine Nagy. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking inventions.
Conclusion
Antal Friesz is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in medication preparation. His contributions, particularly in the development of processes for dronedarone, highlight his commitment to innovation and excellence in the field.